[1]
Rodríguez-Barrios, I. et al. 2020. In vivo testing of safety and immunogenicity of new vaccine candidates against PCV2 designed for a better performance than that showed by currently marketed vaccines. Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria. 9 (abr. 2020).